跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
CLOTRIMAZOLE-FLUCONAZOLE COMBI - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
CLOTRIMAZOLE-FLUCONAZOLE COMBI
Authorized
STANDARD
CLOTRIMAZOLE-FLUCONAZOLE COMBI
Taro Pharmaceuticals Inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
9dcc3db71e606482
Company
Taro Pharmaceuticals Inc
Type
Standard
Approval Details
Approval Id
9dcc3db71e606482
Drug Approval Canada Name
CLOTRIMAZOLE-FLUCONAZOLE COMBI
Product Name
CLOTRIMAZOLE-FLUCONAZOLE COMBI
Status
Marketed
Status Date
2021-02-11
Original Market Date
2017-02-03
Din
02451727
Drug Class
Human
Dosage Form
Capsule , Cream , Kit
Route Of Administration
Oral , Topical
Schedule
OTC
Ahfs
08:14.08
Atc Original
J02AC01 FLUCONAZOLE
Atc Name
j 02 ac 01
Aig Number
0252465001
Company Name
Taro Pharmaceuticals Inc
Company Address
130 East Drive, Brampton, Ontario, Canada, L6T 1C1
Company Detail Path
/organization/taro-pharmaceuticals-inc
Company Information
Pharmaceutical Company Name
Taro Pharmaceuticals Inc
Country Name
Canada
Province Name
Ontario
City Name
brampton,ontario,country_ca
Address
130 East Dr
Active Ingredients
CLOTRIMAZOLE
1 % / W/W
FLUCONAZOLE
150 MG / CAP
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
9dcc3db71e606482
Type
Standard
Back to Health Canada Approvals